Compounds for the treatment of protozoal diseases

Details Compounds for the treatment of protozoal diseases Compounds for the treatment of protozoal diseases

2005-09-27

2005-09-27

Berch, Mark L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S311000, C514S378000, C514S586000, C514S597000, C514S603000, C514S621000, C514S237800, C514S357000, C514S385000, C514S408000, C514S471000, C546S171000, C546S141000, C546S264000, C548S248000, C548S306700, C548S349100, C548S567000, C548S190000, C548S233000, C548S312700, C564S027000, C564S079000, C564S238000, C564S239000, C564S049000, C564S050000, C544S159000, C544S162000, C544S238000, C544S295000, C544S296000, C544S405000, C549S077000

Reexamination Certificate

active

06949567

ABSTRACT:
The invention relates to new diphenylurea having the formula (I)or a salt thereof, whereY is C═O, C═S, C═NH, (C═O)2or SO2;and to processes for the preparation of these compounds and to their use in the treatment of protozoal diseases and to diseases where the inhibition of intracellular protein-degradation pathways is of benefit.

REFERENCES:
patent: 2762742 (1956-09-01), O'Neill et al.
patent: 3529982 (1970-09-01), Luethi et al.
patent: 4003875 (1977-01-01), Luthi et al.
patent: 4405644 (1983-09-01), Kabbe et al.
patent: 4546113 (1985-10-01), Glazer
patent: 5780483 (1998-07-01), Widdowson et al.
patent: 6180675 (2001-01-01), Widdowson et al.
patent: 1 445 186 (1968-10-01), None
patent: 23 34 355 (1975-01-01), None
patent: 29 28 485 (1981-01-01), None
patent: 0 507 732 (1995-04-01), None
patent: 0 990 646 (2000-04-01), None
patent: 755036 (1956-08-01), None
patent: 888965 (1962-02-01), None
patent: WO 94/22807 (1994-10-01), None
patent: WO 95/01168 (1995-01-01), None
patent: WO 95/23132 (1995-08-01), None
patent: WO 96/25157 (1996-08-01), None
patent: WO 96/39382 (1996-12-01), None
patent: WO 97/29743 (1997-08-01), None
patent: WO 98/24785 (1998-06-01), None
patent: WO 98/52558 (1998-11-01), None
patent: WO 99/05096 (1999-02-01), None
patent: WO 99/06354 (1999-02-01), None
patent: WO 99/32110 (1999-07-01), None
patent: WO 99/32463 (1999-07-01), None
patent: WO 99/37666 (1999-07-01), None
patent: WO 00/72840 (2000-12-01), None
patent: WO 00/78726 (2000-12-01), None
patent: WO 01/36383 (2001-05-01), None
Adams et al., “Proteasome Inhibitors: A Novel Class of Potent and Effective Antitumor Agents,”Cancer Research59:2615-2622 (1999).
Adams et al., “Proteasome Inhibition: A New Stratgey in Cancer Treatment,”Investigational New Drugs18:109-121 (2000).
Agejas et al., “A Straightforward Synthesis of 4-Substituted 3,4-Dihydro-1 H-2,1,3-Benzothiadiazine 2,2-Dioxides,”Tetrahedron Letters41:9819-9823 (2000).
Alig et al., “Low Molecular Weight, Non-Peptide Fibrinogen Receptor Antagonists,”J. Med. Chem.35:4393-4407 (1992).
Anastassiadou et al., “Synthesis and Pharmacological Evaluation of Imidazoline Site l1 and l2 Selective Ligands,”Bioorganic&Medicinal Chemistry9:585-592 (2001).
Batey et al., “An Efficient New Protocol for the Formation of Unsymmetrical Tri-and Tetrasubstituted Ureas,”Tetrahedron Letters39:6267-6270 (1998).
Caronna et al., “Nuclear Transformations by Hydrogenolysis: Synthesis of Pyrimidinones From Isoxazoles Derivatives,”Heterocycles24:1377-1380 (1986).
Dewynter et al., “Sulfonyl Bis-N-Oxazolidinone (SBO): A New Versatile Dielectrophile with Sequential Reactivity,”Tetrahedron Letters38:8691-8694 (1997).
Dixit et al., “The Use of Polymer Supports in Organic Synthesis. 17. The Synthesis of Unsymmetrical Diamides and Monoamide Monotosylamides From Symmetrical Diamines,”Israel Journal of Chemistry17:248-252 (1978).
Dougherty et al., “Ring-Closing Metathesis Strategies to Cyclic Sulfamide Peptidomimetics,”Tetrahedron56:9781-9790 (2000).
Dressman et al., “Solid Phase Synthesis of Hydantoins Using a Carbamate Linker and a Novel Cyclization/Cleavage Step,”Tetrahedron Letters37:937-940 (1996).
Gautier et al., “Preparation and Synthetic Uses of Amidines,”The Chemistry of Amidines and Imidates(Chapter 7) pp. 283-348 (1975).
Gomez et al., “An Efficient Procedure for Traceless Solid-Phase Synthesis of N,N'-Substituted Thioureas by Thermolytic Cleavage of Resin-Bound Dithiocarbamates,”J. Comb. Chem.2:75-79 (2000).
Gould, “Salt Selection for Basic Drugs,”International Journal of Pharmaceutics33:201-217 (1986).
Harger et al., “Migration of the Amino Group in the Base-Induced Rearrangements of N-(Aminophosphinoyl)-O-Sulphonylhydroxylamines,”J. Chem. Soc. Perkin Trans.1:2169-2172 (1986).
Houben-Weyl et al., “Kohlensaure-Derivate (Carbonic Acid Derivatives),”Editor Hagemann, Georg Thieme Verlag StuttgartE4:334-357 (1983).
Houben-Weyl et al., “Kohlensaure-Derivate (Carbonic Acid Derivatives),”Editor Hagemann, Georg Thieme Verlag StuttgartE4:484-519 (1983).
Houlihan et al., “Halogenated Mazindol Analogs as Potential Inhibitors of the Cocaine Binding Site at the Dopamine Transporter,”J. Med. Chem.39:4935-4941 (1996).
Hurd et al., “The Preparation and Chemical Properties of Thionamides,”Chem. Rev.61:45-86 (1961).
“Organic Synthesis on Solid Phase”Ed. F.Z. Dorwaldpp. 246-247 (1999).
Kalogeris et al., “Selective Proteasome Inhibitors as Anti-Inflammatory Agents,”Exp. Opin. Invest. Drugs8:1397-1407 (1999).
Katz et al., “A Novel Serine Protease Inhibition Motif Involving a Multi-Centered Short Hydrogen Bonding Network at the Active Site,”J. Mol. Biol.307:1451-1486 (2001).
Lila et al., “Large Scale Preparation of Protected 4-Aminomethylbenzamidine, Application to the Synthesis of the Thrombin Inhibitor, Melagatran,”Synthetic Communications28:4419-4429 (1998).
March, “Reactions, Mechanisms, and Structure,”Advanced Organic Chemistrypp. 396-397 (1992).
Mohan et al., “Solid-Phase Synthesis of N-Substituted Amidinophenoxy Pyridines as Factor XA Inhibitors,”Bioorganic&Medicinal Chemistry Letters8:1877-1882 (1998).
Parlow et al., “Utility of Complementary Molecular Reactivity and Molecular Recognition (CMR/R) Technology and Polymer-Supported Reagents in the Solution-Phase Synthesis of Heterocyclic Carboxamides,”J. Org. Chem.62:5908-5919 (1997).
Pons et al., “A Constrained Diketopiperazine as a New Scaffold for the Synthesis of Peptidomimetics,”Eur. J. Org. Chem.,pp. 853-859 (1998).
Presnell et al., “Oxyanion-Mediated Inhibition of Serine Proteases,”Biochemistry37:17068-17081 (1998).
Saha et al., “1.1′-Carbonybis (3-Methylimidazolium) Triflate: An Efficient Reagent for Aminoacylations,”J. Am. Chem. Soc.111:4856-4859 (1989).
Scarborough et al., “Platelet Glycoprotein IIb-IIIa Antagonists as Prototypical Integrin Blockers: Novel Parenteral and Potential Oral Antithrombotic Agents,”J. Med. Chem.43:3453-3473 (2000).
Scheibye et al., “Studies on Organophosphorus Compounds XXI. The Dimer of p-Methoxyphenylthionophosphine Sulfide as Thiation Reagent, a New Route to Thiocarboxamides,”Bull. Soc. Chim. Belg.87:229-238 (1978).
Theodoridis, “Nitrogen Protecting Groups: Recent Developments and New Applications,”Tetrahedron56:2339-2358 (2000).
Wright et al., “Synthesis and Evaluation of Cryptolepine Analogues for Their Potenital as New Antimalarial Agents,”J. Med. Chem.44:3187-3194 (2001).
Organic Synthesis 62:158-161 (1984).
Khim.-Farm. Zh. 8(6):17-20, Abstract (Chem. Abs. 81:91191) (1974).
Bull. Soc. Chim. Fr., (1):376-382, Abstract (Chem. Abs. 69:10170) (1968).
Organic Synthesis on Solid Phase,Ed. F.Z. Dorwald pp. 331-335 (1999).
Chih et al., “Mammalian Tissue Trypsin-Like Enzymes: Substrate Specificity and Inhibitory Potency of Substituted Isocoumarin Mechanisms-Based Inhibitors, Benzamidine Derivatives, and Arginine Fluoroalkyl Ketone Transition-State Inhibitors,”Arch. Biochem. Biophys.316:808-814, Abstract (1995).
Winkelmann et al., “Tuberculostatic 1,3-diarylthioureas. I,”Abstract&Arzneim.-Forsch19:543-558, Abstract (1969).
Wagner et al.,Arzneimittel. Forsch.,19:719-730, Abstract (1969).
Ozaki et al., “Preparation of 3,5-Diphenyl-1-1,2,4-Triazole Derivatives as Insecticides and Acaricides,” JP 08 092224, Abstract (1996).
Edgar et al., “Leishmania Donovani, Plasmodium Berghei, Trypanosoma Rhodesiense: Antiprotozoal Effects of Some Amidine Types,”Exp. Parasitol.52:404-413, Abstract (1981).
Prouty et al., “Effects of Protease Inhibitors on Protein Breakdown inEscherichia Coli,” J. Biol. Chem.247:3341-3352, Abstract (1972).
Wojciech et al., ȁ

Affiliated with

Also associated with

Rating

Compounds for the treatment of protozoal diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds for the treatment of protozoal diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for the treatment of protozoal diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3413366